Live Chat

Amgen लाइव चार्ट

उपकरण मूल बातें

Weekly Search
Weekly
Daily
दिनांक बंद करें परिवर्तन (%) परिवर्तित करें खुला उच्च कम

नवीनतम समाचार

Frances Wang 2024 Nov 21, 16:05

Asian Market Update: Hang Seng Index Falls on Baidu Slumps

Indices
Frances Wang 2024 Nov 21, 16:00

Stock Market Today: Dow and S&P 500 Post Gains Ahead of Nvidia Earnings

CFD Trading
Frances Wang 2024 Nov 21, 16:00

Super Micro Stock Surges on Decision to Maintain Nasdaq Listing

Stocks
Echoes in Bitcoin rise?
Neil Wilson 2024 Nov 21, 16:00

Silver Thursday & the Hunt Brothers: History Repeating?

Cryptocurrencies CFD Trading
Frances Wang 2024 Nov 20, 16:00

MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K

Cryptocurrencies
Frances Wang 2024 Nov 20, 16:00

Nasdaq futures decline, Nvidia shares dip following the earnings report

Indices CFD Trading Stocks
Mixed market performance
Neil Wilson 2024 Nov 20, 16:00

Markets Mixed Amid Inflation, Tech Rally, and UK Economic Woes

USD Tech S&P 500
Frances Wang 2024 Nov 19, 16:00

Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024

NVDA Stocks

जानकारी

स्प्रेड

1.84

स्प्रेड (%)

0.6265 %

लीवरेज

1:5

ओवरनाइट ब्याज विक्रय

-0.0597 %

overnight_interest_sell

-0.0292 %

मुद्रा

USD

ट्रेडिंग घंटे

बाज़ार बंद है

सोमवार

14:31 - 20:59

मंगवार

14:31-20:59

बुधवार

14:31-20:59

गुरुवार

14:31-20:59

शुक्रवार

14:31-20:59

विश्लेषण और सांख्यिकी

खुला

---

पिछला बंद

---

52 सप्ताह उच्च/निम्न्च

--- – ---

बाज़ार आकार

155830812672

बकाया शेयर

537532992

प्राप्ति की तिथि (आगे)

1999-11-22

लाभांश आय 

2024-12-09

पूर्व-लाभांश तिथि

2024-11-18

अग्रिम वार्षिक लाभांश दर 

9

अग्रिम वार्षिक लाभांश आय

0.031

EPS

7.83

इस उपकरण के बारे में अधिक जानें

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

संबंधित उपकरण

संपत्ति
बेचें
खरीदें
(%) परिवर्तित करें
view_all_instruments
Trustpilot
Live Chat